| P2093 | author name string | Isenberg D | |
| | Waxman J | |
| | Baker T | |
| | Tickle S | |
| | Docherty A | |
| | Wasan H | |
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| | Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues | Q34784429 |
| | The matrix metalloproteinases and their natural inhibitors: prospects for treating degenerative tissue diseases | Q35301529 |
| | Stromal expression of 72 kda type IV collagenase (MMP-2) and TIMP-2 mRNAs in colorectal neoplasia | Q35831955 |
| | Expression of metalloproteinases and their inhibitors in primary pulmonary carcinomas | Q35994721 |
| | Coordinated expression of extracellular matrix-degrading proteinases and their inhibitors regulates mammary epithelial function during involution | Q36531772 |
| | Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation | Q36618743 |
| | Response Criteria in Urologic Malignancies | Q40152165 |
| | Stromelysin is an activator of procollagenase. A study with natural and recombinant enzymes | Q41866734 |
| | Dissociation of tissue inhibitor of metalloproteinases (TIMP) from enzyme complexes yields fully active inhibitor | Q42227575 |
| | Localization of messenger RNA for Mr 72,000 and 92,000 type IV collagenases in human skin cancers by in situ hybridization | Q42450642 |
| | Expression of stromelysin 3 in the stromal elements of human basal cell carcinoma | Q42452890 |
| | The architecture of cancer | Q42760974 |
| | Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours | Q44757884 |
| | Detection of stromelysin and collagenase in synovial fluid from patients with rheumatoid arthritis and posttraumatic knee injury | Q67531153 |
| | Correlation of serum metalloproteinase levels with lung cancer metastasis and response to therapy | Q67855439 |
| | Immunological quantitation of levels of tissue inhibitor of metalloproteinase-1 in human colon cancer | Q68032774 |
| | Immunoassays for the detection of human collagenase, stromelysin, tissue inhibitor of metalloproteinases (TIMP) and enzyme-inhibitor complexes | Q68078112 |
| | A pharmacological evaluation of a new 3-month depot preparation of buserelin for prostatic cancer | Q69259448 |
| | Gelatin-degrading type IV collagenase isolated from human small cell lung cancer | Q69349029 |
| | Role of collagenase in colonic anastomoses: a reappraisal | Q69824146 |
| | Immunolocalization of collagenase and tissue inhibitor of metalloproteinases (TIMP) in hypertrophic scar tissue | Q70153180 |
| | Increased stromelysin 3 gene expression is associated with increased local invasiveness in head and neck squamous cell carcinomas | Q72066821 |
| | Type IV collagenase (M(r) 72,000) expression in human prostate: benign and malignant tissue | Q72069125 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 506-512 | |
| P577 | publication date | 1994-09-01 | |
| P1433 | published in | British Journal of Cancer | Q326309 |
| P1476 | title | Serum metalloproteinases and their inhibitors: markers for malignant potential | |
| P478 | volume | 70 | |